The US market for cardiac rhythm management (CRM) devices is expected to grow by approximately $1.1 billion at a compound annual growth rate (CAGR) of 2.9% over the next five years; diagnostic CRM products are forecast to grow at a CAGR of 4.8%, while therapeutic CRM products will grow at a CAGR of 2.7%.
AF Ablation Procedures Driving CRM Market Expansion
Cardiac rhythm management device sales in the US are projected to grow at a compound annual rate of 2.9%, increasing to an estimated $8.2 billion in the year 2019. Two of the fastest growing sectors of the market, electrophysiology and ablation devices, will be driven by a 10% to 20% growth in the number of patients treated for atrial fibrillation.